213 related articles for article (PubMed ID: 28802057)
1. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
[TBL] [Abstract][Full Text] [Related]
2. Cellular plasticity in the breast cancer ecosystem.
Pietras K; Sjölund J
Ups J Med Sci; 2024; 129():. PubMed ID: 38571887
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence.
Reid SE; Pantaleo J; Bolivar P; Bocci M; Sjölund J; Morsing M; Cordero E; Larsson S; Malmberg M; Seashore-Ludlow B; Pietras K
Oncogene; 2024 Apr; 43(15):1113-1126. PubMed ID: 38388711
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study.
Kashyap D; Bhattacharya S; Irinike S; Khare S; Das A; Singh G; Bal A
Breast Dis; 2024; 43(1):25-36. PubMed ID: 38517765
[TBL] [Abstract][Full Text] [Related]
5. A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.
Yu S; Lu Y; Su A; Chen J; Li J; Zhou B; Liu X; Xia Q; Li Y; Li J; Huang M; Ye Y; Zhao Q; Jiang S; Yan X; Wang X; Di C; Pan J; Su S
Adv Sci (Weinh); 2021 Oct; 8(19):e2101848. PubMed ID: 34363355
[TBL] [Abstract][Full Text] [Related]
6. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.
Truong DD; Kratz A; Park JG; Barrientos ES; Saini H; Nguyen T; Pockaj B; Mouneimne G; LaBaer J; Nikkhah M
Cancer Res; 2019 Jun; 79(12):3139-3151. PubMed ID: 30992322
[TBL] [Abstract][Full Text] [Related]
7. Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry.
Røgenes H; Finne K; Winge I; Akslen LA; Östman A; Milosevic V
Front Immunol; 2024; 15():1325191. PubMed ID: 38711512
[TBL] [Abstract][Full Text] [Related]
8. Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.
Bagger MM; Sjölund J; Kim J; Kohler KT; Villadsen R; Jafari A; Kassem M; Pietras K; Rønnov-Jessen L; Petersen OW
Breast Cancer Res; 2024 Jan; 26(1):11. PubMed ID: 38229104
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer.
Taguchi R; Yamaguchi-Tanaka M; Takagi K; Sato A; Miki Y; Miyashita M; Suzuki T
Acta Histochem Cytochem; 2024 Apr; 57(2):75-83. PubMed ID: 38695037
[TBL] [Abstract][Full Text] [Related]
10. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development.
Varveri A; Papadopoulou M; Papadovasilakis Z; Compeer EB; Legaki AI; Delis A; Damaskou V; Boon L; Papadogiorgaki S; Samiotaki M; Foukas PG; Eliopoulos AG; Hatzioannou A; Alissafi T; Dustin ML; Verginis P
Nat Commun; 2024 Jun; 15(1):4988. PubMed ID: 38862534
[TBL] [Abstract][Full Text] [Related]
11. Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line:
Urban L; Novák Š; Čoma M; Dvořánková B; Lacina L; Šáchová J; Hradilová M; Svatoňová P; Kolář M; Strnad H; Březinová J; Smetana K; Gál P; Szabo P
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975220
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical Galectin-3 expression in tumor and cancer-associated fibroblasts in invasive ductal carcinomas of breast and their relationship with clinicopathological parameters.
Cakir Y; Talu CK; Trabulus DC; Mermut O
Indian J Pathol Microbiol; 2023; 66(3):456-464. PubMed ID: 37530324
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer.
Liang T; Tao T; Wu K; Liu L; Xu W; Zhou D; Fang H; Ding Q; Huang G; Wu S
Adv Sci (Weinh); 2023 Nov; 10(31):e2303230. PubMed ID: 37743226
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin-modifying protein CBX4 in squamous cell carcinoma.
Fisher ML; Balinth S; Hwangbo Y; Wu C; Ballon C; Goldberg GL; Mills AA
Carcinogenesis; 2023 Aug; 44(6):485-496. PubMed ID: 37463322
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells and cancer-associated fibroblasts as a therapeutic strategy for breast cancer.
Borzone FR; Giorello MB; Sanmartin MC; Yannarelli G; Martinez LM; Chasseing NA
Br J Pharmacol; 2024 Jan; 181(2):238-256. PubMed ID: 35485850
[TBL] [Abstract][Full Text] [Related]
16. Differential remodeling of extracellular matrices by breast cancer initiating cells.
Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
[TBL] [Abstract][Full Text] [Related]
17. Re-interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation.
Edwards PA
J Pathol; 2023 May; 260(1):1-4. PubMed ID: 36811403
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling.
Fang Y; Xiao X; Wang J; Dasari S; Pepin D; Nephew KP; Zamarin D; Mitra AK
NPJ Precis Oncol; 2024 Jan; 8(1):7. PubMed ID: 38191909
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy.
Kadel D; Zhang Y; Sun HR; Zhao Y; Dong QZ; Qin LX
Cell Biol Toxicol; 2019 Oct; 35(5):407-421. PubMed ID: 30680600
[TBL] [Abstract][Full Text] [Related]
20. Role of HMGB1 and its associated signaling pathways in human malignancies.
Idoudi S; Bedhiafi T; Pedersen S; Elahtem M; Alremawi I; Akhtar S; Dermime S; Merhi M; Uddin S
Cell Signal; 2023 Dec; 112():110904. PubMed ID: 37757902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
